CURRENT DIABETES REVIEWS

Scope & Guideline

Cutting-edge Reviews for Diabetes Research

Introduction

Delve into the academic richness of CURRENT DIABETES REVIEWS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1573-3998
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryUnited Arab Emirates
TypeJournal
Converge1996, from 2005 to 2024
AbbreviationCURR DIABETES REV / Curr. Diabetes Reviews
Frequency9 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

CURRENT DIABETES REVIEWS focuses on a broad spectrum of diabetes-related research, emphasizing innovative treatment strategies, emerging technologies, and comprehensive management approaches for diabetes mellitus and its complications.
  1. Diabetes Management and Therapy:
    Research exploring various therapeutic strategies, including pharmacological treatments, lifestyle interventions, and novel medications, aimed at improving glycemic control and managing complications associated with diabetes.
  2. Complications of Diabetes:
    Investigation into the pathophysiology, diagnosis, and management of diabetes complications, such as neuropathy, retinopathy, nephropathy, and cardiovascular diseases.
  3. Emerging Technologies in Diabetes Care:
    Studies on technological advancements, including artificial intelligence, machine learning, and telemedicine, aimed at enhancing diabetes care and patient management.
  4. Psychosocial Aspects of Diabetes:
    Research examining the psychosocial factors influencing diabetes management, including mental health, self-care behaviors, and patient education.
  5. Dietary and Nutritional Interventions:
    Exploration of dietary approaches, including the role of functional foods, herbal remedies, and nutritional supplements in the prevention and management of diabetes.
  6. Public Health and Epidemiology:
    Studies addressing the prevalence, risk factors, and public health implications of diabetes globally, with a focus on specific populations and regions.
CURRENT DIABETES REVIEWS has shown a dynamic shift towards certain emerging themes that reflect the latest trends and priorities in diabetes research, highlighting the evolving landscape of the field.
  1. Integration of Technology in Diabetes Management:
    Recent publications emphasize the role of technology, such as continuous glucose monitoring systems, telemedicine, and digital health applications, in improving diabetes management and patient outcomes.
  2. Personalized Medicine and Genomics:
    An increasing number of studies focus on personalized treatment approaches based on genetic and phenotypic variations among individuals with diabetes, demonstrating a shift towards tailored therapies.
  3. Comorbidity and Multidisciplinary Approaches:
    Emerging research highlights the intersection of diabetes with other chronic conditions, advocating for multidisciplinary strategies that address diabetes in conjunction with cardiovascular health, obesity, and mental health.
  4. Psychosocial Interventions:
    There is a growing recognition of the importance of psychosocial factors in diabetes management, leading to an increase in studies that examine behavioral interventions and mental health support for patients.
  5. Dietary Patterns and Nutraceuticals:
    Research on the role of specific dietary patterns, functional foods, and nutraceuticals in diabetes prevention and management is trending upwards, reflecting an interest in holistic and lifestyle-based interventions.

Declining or Waning

While CURRENT DIABETES REVIEWS continues to explore a wide range of diabetes-related topics, certain areas of focus have seen a decline in recent publications, indicating a potential shift in research priorities.
  1. Traditional Pharmacotherapy:
    There has been a noticeable decrease in studies solely focused on traditional pharmacological treatments for diabetes, as newer therapeutic approaches and combination therapies gain prominence.
  2. Basic Science Research on Diabetes:
    Research that primarily addresses basic scientific mechanisms without direct clinical applications appears to be waning, as the journal increasingly emphasizes translational and applied research.
  3. Single-Condition Studies:
    The focus on diabetes in isolation, without consideration of comorbidities or broader health implications, is declining in favor of more integrative approaches that consider diabetes alongside conditions like cardiovascular diseases and metabolic syndrome.

Similar Journals

Acta Endocrinologica-Bucharest

Nurturing emerging ideas in endocrinology and metabolism.
Publisher: EDITURA ACAD ROMANEISSN: 1841-0987Frequency: 4 issues/year

Acta Endocrinologica-Bucharest is a vital resource for those engaged in the study and practice of endocrinology, diabetes, and metabolic research. Published by EDITURA ACAD ROMANE, this journal emphasizes the dissemination of high-quality research and insights specific to the fields of endocrinology and autonomic systems. Although categorized in the lower quartiles of its subject areas according to the latest rankings—Q4 in Endocrine and Autonomic Systems and Q4 in Endocrinology—it serves as an important platform for emerging scientific ideas and collaborative studies within the endocrinology community. With an ISSN of 1841-0987 and an E-ISSN of 1843-066X, the journal provides a significant opportunity for authors to contribute to the growing body of knowledge in these fields from its base in Romania. Researchers and practitioners alike will find valuable contributions that reflect both contemporary challenges and advances in endocrinology, reinforcing the journal's commitment to enhancing scholarly communication.

Journal of Diabetes and Metabolic Disorders

Transforming Diabetes Knowledge into Practice
Publisher: SPRINGER INT PUBL AGISSN: Frequency:

The Journal of Diabetes and Metabolic Disorders, published by SPRINGER INT PUBL AG, is a premier academic journal dedicated to advancing research in the fields of endocrinology, diabetes, and metabolism. With an E-ISSN of 2251-6581, this journal plays a crucial role in disseminating high-quality research findings from 2012 to 2024, serving as a valuable resource for researchers, practitioners, and students alike. Notably, it has achieved impressive rankings, being placed in the Q2 quartile for Internal Medicine and Q3 for Endocrinology, Diabetes, and Metabolism in 2023, reflecting its influence within the scientific community. The Journal’s commitment to open access ensures that its comprehensive articles, encompassing topics from metabolic disorders to novel therapeutic approaches, are readily available to a global audience. Position yourself at the forefront of medical advancements—contribute to and benefit from the pivotal research presented in this journal.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Fostering Collaboration in Endocrinology Research
Publisher: GEORG THIEME VERLAG KGISSN: 0947-7349Frequency: 10 issues/year

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.

Diabetology International

Bridging academia and practice in diabetes care.
Publisher: SPRINGER JAPAN KKISSN: 2190-1678Frequency: 4 issues/year

Diabetology International, published by Springer Japan KK, is a leading journal dedicated to the field of diabetes research. With an ISSN of 2190-1678 and E-ISSN of 2190-1686, this journal plays a pivotal role in disseminating innovative studies and findings that advance understanding in endocrinology, diabetes, and metabolism. Its rigorous peer-review process ensures the publication of high-quality research articles, review papers, and clinical studies, making it a valuable resource for researchers, healthcare professionals, and students. The journal is indexed in Scopus and maintains respectable rankings in its categories, standing at Q3 in Endocrinology, Diabetes and Metabolism, and Q2 in Internal Medicine as of 2023. Furthermore, the journal facilitates collaborations and promotes the exchange of ideas from its base in Tokyo, Japan, helping to bridge the gap between academia and clinical practice. As it converges through the years from 2010 to 2024, Diabetology International remains committed to addressing the evolving challenges in diabetes care and research, supporting the global community's pursuit of knowledge in this crucial field.

Diabetes & Metabolism Journal

Transforming diabetes research into actionable insights.
Publisher: KOREAN DIABETES ASSOCISSN: 2233-6079Frequency: 6 issues/year

Diabetes & Metabolism Journal, published by the Korean Diabetes Association, is a leading open-access journal dedicated to advancing the field of endocrinology, with a specific focus on diabetes and metabolism. Since its establishment in 1991, the journal has provided a robust platform for disseminating high-quality research, contributing significantly to our understanding of diabetes pathophysiology, treatment, and prevention strategies. The journal boasts an impressive impact factor, ranking in the top quartile (Q1) of its category and occupying the 28th position out of 244 in Scopus rankings, which places it in the 88th percentile among its peers. With its commitment to open access, researchers, professionals, and students globally can explore the latest findings and innovative solutions in diabetes research. The journal continues to serve as an essential resource for those dedicated to improving patient outcomes and advancing scientific knowledge in the metabolic disorders domain.

Journal of Diabetology

Driving progress in diabetes research and treatment.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2543-3288Frequency: 3 issues/year

The Journal of Diabetology, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 2010, this Open Access journal has provided researchers and healthcare professionals with a wealth of knowledge through rigorous peer-reviewed articles that cover clinical research, epidemiology, and innovative treatment strategies. With an E-ISSN of 2078-7685 and a commitment to disseminating high-quality scientific work, the journal plays a pivotal role in contributing to the global discourse on diabetes care and prevention. Its dedication to accessibility enhances its impact on both established scholars and emerging researchers seeking to make meaningful contributions in the field. By fostering a collaborative environment, the Journal of Diabetology aims to bridge the gap between research and practical implementation, ultimately improving outcomes for individuals affected by diabetes.

Diabetes Mellitus

Advancing knowledge in diabetes and metabolism.
Publisher: ENDOCRINOLOGY RESEARCH CENTREISSN: 2072-0351Frequency: 4 issues/year

Diabetes Mellitus, published by the Endocrinology Research Centre in the Russian Federation, is an esteemed open-access journal dedicated to the field of endocrinology, diabetes, and metabolism. Since its inception in 1998, this journal has been a pivotal platform for disseminating cutting-edge research and comprehensive reviews that address the multifaceted challenges posed by diabetes. With its current quartile ranking of Q4 in Endocrinology and the associated fields, as well as commendable involvement in the broader scope of Internal Medicine, Diabetes Mellitus plays a crucial role in enhancing clinical practices and informing innovative therapeutic strategies. The journal caters to a diverse audience of researchers, healthcare professionals, and students, particularly those seeking to expand their knowledge and improve patient outcomes in diabetes care. With a commitment to fostering scientific conversation and collaboration, Diabetes Mellitus is an invaluable resource for anyone engaged in the fight against diabetes and its complications.

DIABETES CARE

Leading the way in diabetes research excellence.
Publisher: AMER DIABETES ASSOCISSN: 0149-5992Frequency: 12 issues/year

DIABETES CARE, published by the American Diabetes Association, is a premier journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 1978, this journal has maintained a commitment to disseminating high-quality research, evidenced by its prestigious ranking in the Q1 category across multiple fields including Advanced and Specialized Nursing, Endocrinology, Diabetes and Metabolism, and Internal Medicine. With an impressive impact factor and distinguished Scopus rankings, DIABETES CARE serves as an essential resource for researchers, clinicians, and students alike, facilitating the exchange of knowledge and fostering innovation in diabetes care. Although not an open-access publication, the journal offers various ways to access groundbreaking studies and advancements in the field. This commitment to excellence reflects the journal's vital role in shaping diabetes research and clinical practices globally.

Journal of Diabetes

Elevating the conversation in endocrinology and diabetes.
Publisher: WILEYISSN: 1753-0393Frequency: 12 issues/year

The Journal of Diabetes, published by WILEY, is a premier Open Access platform since 2022, dedicated to advancing knowledge in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 1753-0393 and an E-ISSN of 1753-0407, this journal provides a vital resource for researchers and practitioners looking to keep up with the latest findings and trends in diabetes management and treatment. As of 2023, it holds a commendable Q2 rating in its category and ranks #78 out of 244 in the Scopus classification, placing it in the 68th percentile, thus affirming its significance in the academic community. Covering a timeline from 2009 to 2024, the journal invites submissions that contribute to the understanding of diabetes pathophysiology, innovative therapies, and clinical practices, making it an essential read for anyone dedicated to improving patient outcomes in diabetes care.

DIABETIC MEDICINE

Connecting researchers and clinicians to enhance diabetes outcomes.
Publisher: WILEYISSN: 0742-3071Frequency: 12 issues/year

DIABETIC MEDICINE is a leading peer-reviewed journal published by Wiley, dedicated to advancing the field of endocrinology, specifically focusing on the pathophysiology, management, and prevention of diabetes mellitus and its complications. With an impressive impact factor reflecting its significant role in shaping clinical practice and research, DIABETIC MEDICINE holds a prominent position among its peers, categorized in the Q1 quartiles for Endocrinology, Diabetes and Metabolism, and Internal Medicine. Since its inception in 1984, the journal has provided a platform for rigorous and innovative research, fostering collaborative efforts among researchers, clinicians, and students to enhance diabetes care. The journal is esteemed for its high-ranking performance in Scopus, highlighted by its ranking of #33 in Internal Medicine and #64 in Endocrinology, Diabetes, and Metabolism. By offering insightful access to groundbreaking studies and reviews, DIABETIC MEDICINE plays a crucial role in informing policy and improving medical outcomes for individuals with diabetes, making it an essential resource for those in medical and clinical research fields.